Elizabeth H. and James S. McDonnell III Genome Institute
World leader in the fast-paced, constantly changing field of genomics
To unveil the secrets of the genome,
the blueprint of life,
to improve the lives of people everywhere
GTAC@MGI provides cutting-edge, cost-effective sequencing, and analysis technologies to collaborators. We are committed to generating the highest quality data and providing excellent value-added services and resources.
Genome Engineering &
Stem Cell Center
GESC@MGI facilitates collaborators and customers with functional genomic studies through the use of patient-derived iPSCs and the generation of modified cells and organisms using genome editing technologies.
Mass Spectrometry Technology Access Center
MTAC@MGI provides state-of-art proteomics, metabolomics, lipidomics, and imaging MS technologies to address timely questions in basic, translational, and clinical research by supporting researchers worldwide
Since its inception in 1993, the McDonnell Genome Institute has played a vital role in the field of genome sequencing, receiving over $1.3 billion in research funding. Today, MGI has taken the COVID-19 Pandemic head on by developing a saliva based test to help detect who has contracted the illness